Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

This study has been completed.
Sponsor:
Collaborators:
CORE
St Mark's Hospital Foundation
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT00180648
First received: September 12, 2005
Last updated: February 19, 2016
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)